Back to Search
SETH HOLLENBACH, M.D.
M.D.
Urology Physician
NPI: 1437343845IndividualAccepts Medicare
Education
UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Class of 2006
Research & Publications (20)
Cleavage of in vitro and in vivo formed lens protein cross-links by a novel cross-link breaker.
PMID 12619891·Mol Cell Biochem·2003
8-other
Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor.
PMID 19297154·Bioorg Med Chem Lett·2009
4-observational
Identification of 4-piperazin-1-yl-quinazoline template based aryl and benzyl thioureas as potent, selective, and orally bioavailable inhibitors of platelet-derived growth factor (PDGF) receptor.
PMID 15341941·Bioorg Med Chem Lett·2004
7-preclinical
N,N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitors.
PMID 15080981·Bioorg Med Chem Lett·2004
8-other
Discovery of novel 2,8-diazaspiro[4.5]decanes as orally active glycoprotein IIb-IIIa antagonists.
PMID 15056002·J Med Chem·2004
7-preclinical
Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors with improved functional activity.
PMID 15013007·Bioorg Med Chem Lett·2004
7-preclinical
Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors incorporating substituted biphenyl P4 motifs.
PMID 15013006·Bioorg Med Chem Lett·2004
7-preclinical
Short-term intravenous eptifibatide infusion combined with reduced dose recombinant tissue plasminogen activator inhibits platelet recruitment at sites of coronary artery injury.
PMID 14736451·J Am Coll Cardiol·2004
7-preclinical
Inhibition of purified factor Xa amidolytic activity may not be predictive of inhibition of in vivo thrombosis: implications for identification of therapeutically active inhibitors.
PMID 12750119·Arterioscler Thromb Vasc Biol·2003
4-observational
Design, synthesis, and structure-activity relationships of unsubstituted piperazinone-based transition state factor Xa inhibitors.
PMID 12639567·Bioorg Med Chem Lett·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1662 HIGDON FERRY RD, SUITE 140
HOT SPRINGS, AR 71913 - Phone
- (501) 525-4555
Quick Facts
- NPI
- 1437343845
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 20
- Publications
- 20
Are you this provider?
Claim Your Profile